drugset / Press release
First patient enrolled in the phase I/II clinical trial testing FG001 in patients with high grade glioma
2020-11-09 · FluoGuide A/S · original fluoguide.com ↗
Copenhagen, Denmark, 9 November 2020 – FluoGuide A/S (“FluoGuide” or “the Company”) is pleased to inform that the first patient today was enrolled in the clinical trial testing safety and efficacy of FG001 in guiding high grade glioma surgery.
The release as fetched from its publisher. fluoguide.com ↗